Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Cancers|November 11, 2022
Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor-Induced Kidney InjuryAla Abudayyeh, Liye Suo, Heather Lin, et al.ACR Open Rheumatology|March 6, 2026
Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune VasculitisJuan Sevillano, Noha Abdel-Wahab, Yixuan Zhou, et al.Journal of Cancer Survivorship : Research and Practice|October 27, 2015
Assessing information needs on bone health in cancer survivorsJude K A des Bordes, Noha Abdel-Wahab, Maria Suarez-Almazor, et al.Plos One|June 21, 2019
A comprehensive scoping review to identify standards for the development of health information resources on the internetNoha Abdel-Wahab, Devesh Rai, Harish Siddhanamatha, et al.European Radiology|October 18, 2022
Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: a retrospective series of biopsy-proven casesMuhammad O Awiwi, Ala Abudayyeh, Noha Abdel-Wahab, et al.BMJ Oncology|January 31, 2025
Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitorsCarrie Ye, Bo Zhao, William D Leslie, et al.Journal for Immunotherapy of Cancer|July 29, 2020
Checkpoint inhibitor-related renal vasculitis and use of rituximabOmar Mamlouk, Jamie S Lin, Maen Abdelrahim, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 1, 2020
Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint InhibitorsJeffrey Aldrich, Xerxes Pundole, Sudhakar Tummala, et al.Archives of Osteoporosis|February 10, 2021
Quality appraisal of educational websites about osteoporosis and bone healthMaria A Lopez-Olivo, Jude K A des Bordes, Maha N Syed, et al.Cancers|November 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor ResponseVishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, et al.Pageof 6